NIP
Nicholas Investment Partners Portfolio holdings
AUM
$1.12B
This Quarter Return
+4.84%
1 Year Return
+50.66%
3 Year Return
+286.38%
5 Year Return
+525.06%
10 Year Return
+2,262.45%
AUM
$1.58B
AUM Growth
+$1.58B
(+15%)
Cap. Flow
+$192M
Cap. Flow
% of AUM
12.13%
Top 10 Holdings %
Top 10 Hldgs %
18.14%
Holding
230
New
32
Increased
93
Reduced
20
Closed
27
Top Buys
| 1 |
Ascendis Pharma
ASND
|
$11.4M |
| 2 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$9.58M |
| 3 |
Maravai LifeSciences
MRVI
|
$9.55M |
| 4 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$9.02M |
| 5 |
Microsoft
MSFT
|
$8.46M |
Top Sells
| 1 |
AMRS
Amyris Inc.
AMRS
|
$13M |
| 2 |
DMTK
DermTech, Inc. Common Stock
DMTK
|
$12.9M |
| 3 |
OSH
Oak Street Health, Inc.
OSH
|
$11.8M |
| 4 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$9.93M |
| 5 |
Texas Capital Bancshares
TCBI
|
$8.68M |
Sector Composition
| 1 | Healthcare | 30.22% |
| 2 | Technology | 18.11% |
| 3 | Financials | 10.26% |
| 4 | Industrials | 8.95% |
| 5 | Consumer Discretionary | 7.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Guardant Health
GH
$8.41B
| $11.2M | 0.71% | 112,213 +17,850 | +19% | +$1.79M |
|
52
ASML
ASML
$292B
| $10.4M | 0.66% | 13,051 +5,337 | +69% | +$4.25M |
|
53
Caesars Entertainment
CZR
$5.57B
| $10.2M | 0.65% | 109,572 | – | – |
|
54
MaxCyte
MXCT
$148M
| $10.1M | 0.64% | 986,301 +6,179 | +0.6% | +$63K |
|
|
VERV
55
DELISTED
Verve Therapeutics
VERV
| $10M | 0.63% | 271,589 +139,289 | +105% | +$5.14M |
|
56
Lam Research
LRCX
$127B
| $9.95M | 0.63% | 13,832 +3,198 | +30% | +$2.3M |
|
57
Ameresco
AMRC
$1.34B
| $9.8M | 0.62% | 120,369 +11,588 | +11% | +$944K |
|
|
NARI
58
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $9.58M | 0.61% | +104,932 | New | +$9.58M |
|
|
59
Maravai LifeSciences
MRVI
$350M
| $9.55M | 0.6% | +227,823 | New | +$9.55M |
|
60
Regal Rexnord
RRX
$9.91B
| $9.23M | 0.58% | 54,242 +10,745 | +25% | +$1.83M |
|
61
Morgan Stanley
MS
$240B
| $9.08M | 0.57% | 92,500 +2,500 | +3% | +$245K |
|
|
ISEE
62
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $9.02M | 0.57% | +539,730 | New | +$9.02M |
|
63
Apollo Global Management
APO
$77.9B
| $8.93M | 0.57% | 123,300 +48,300 | +64% | +$3.5M |
|
64
Airbnb
ABNB
$79.9B
| $8.76M | 0.55% | 52,639 +45,835 | +674% | +$7.63M |
|
|
AVGOP
65
DELISTED
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
| – | – | 0 | – | – |
|
66
Vertex Pharmaceuticals
VRTX
$100B
| $8.41M | 0.53% | +38,287 | New | +$8.41M |
|
67
VistaGen Therapeutics
VTGN
$102M
| $8.36M | 0.53% | 4,288,077 +1,501,723 | +54% | +$2.93M |
|
|
OMIC
68
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $8.34M | 0.53% | 721,027 +71,234 | +11% | +$823K |
|
69
CrowdStrike
CRWD
$106B
| $8.28M | 0.52% | 40,455 +12,331 | +44% | +$2.52M |
|
70
Exact Sciences
EXAS
$8.98B
| $8.22M | 0.52% | 105,578 -12,681 | -11% | -$987K |
|
71
Veeva Systems
VEEV
$44B
| $8.12M | 0.51% | 31,796 -14,447 | -31% | -$3.69M |
|
72
JPMorgan Chase
JPM
$829B
| $8.08M | 0.51% | 51,000 +21,000 | +70% | +$3.33M |
|
73
Adobe
ADBE
$151B
| $8.02M | 0.51% | 14,137 +8,352 | +144% | +$4.74M |
|
74
908 Devices
MASS
$226M
| $8.02M | 0.51% | 309,833 +22,018 | +8% | +$570K |
|
75
Amazon
AMZN
$2.44T
| $7.95M | 0.5% | 2,385 +552 | +30% | +$1.84M |
|